ArticleOncoTargets and therapy2019

Intersectin 1 (ITSN1) identified by comprehensive bioinformatic analysis and experimental validation as a key candidate biological target in breast cancer.

Chen Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.